Related Experiment Video
Updated: Jun 1, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Antibiotics in the clinical pipeline in 2011
Mark S Butler1, Matthew A Cooper
1Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Abstract:
The emergence of multi-drug-resistant bacteria and the lack of new antibiotics in the antibiotic drug development pipeline, especially those with new modes of action, is a major health concern. This review lists the 20 new antibiotics launched since 2000 and records the 40 compounds currently in active clinical development. Compounds in the pipeline from new antibiotic classes are reviewed in detail with reference to their development status, mode of action, spectrum of activity and lead discovery. In addition, the NP or synthetic derivation is discussed, with activity against Gram-negative bacteria highlighted.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
10:49Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Related Concept Videos
Antibiotic Selection
Clinical Significance of Antibiotic Resistance
Production of Antibiotics
Inhibitors of Bacterial Protein Synthesis
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...